GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dear Sirs, Sub: Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Oil, 0.01% (Ear Drops) With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Thanking you, GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sub: Glenmark Pharmaceuticals Announces New Data on GBR 1302, a HER2xCD3 Bispecific Antibody, Presented at the ESMO Immuno-Oncology Congress 2018 With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Glenmark gets USFDA nod for skin ointment
Glenmark Pharmaceuticals has received final approval from the US health regulator to market Hydrocortisone Valerate ointment, used to treat a variety GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dear Sirs, Sub: Glenmark Pharmaceuticals receives ANDA approval for Hydrocortisone Valerate Ointment USP, 0.2% With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Transfer Of Operations Of Registrar And Share Transfer Agent
Transfer of Operations of Registrar and Share Transfer Agent from Karvy Computershare Private Limited to Karvy Fintech Private Limited. Glenmark gets tentative USFDA nod for skin treatment drug
Glenmark Pharmaceuticals has received tentative nod from the US health regulator for Clobetasol Propionate foam, used to treat inflammation and itchin Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sub: Glenmark Pharmaceuticals receives tentative ANDA approval for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation) With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Glenmark gets USFDA nod for pneumonia treatment drug
Glenmark Pharmaceuticals on Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and treatme Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sub: Glenmark Pharmaceuticals receives ANDA approval for Atovaquone Oral Suspension USP, 750 mg/5 mL With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. R&D; spend will continue to be around 12% of revenue, says Glenmark CMD
A bigger chunk of our R&D investment is towards our innovative and specialty pipeline, said CMD